Hints and tips:
Related Special Reports
...Haleon, GlaxoSmithKline’s consumer healthcare venture with Pfizer, is down about 5 per cent from its July listing price....
...Its failed attempts to buy UK drugmaker GlaxoSmithKline’s consumer healthcare business, a politically fraught fight with Ben & Jerry’s and the arrival of the billionaire activist Nelson Peltz on Unilever...
...GlaxoSmithKline and Pfizer are holding out for an improved bid of at least £60bn for their consumer healthcare joint venture, bolstered by shareholder opposition to Unilever’s £50bn offer....
...“GSK Consumer Healthcare is a leader in the attractive consumer health space and would be a strong strategic fit as Unilever continues to reshape its portfolio....
...And personalised products such as CAR-T have proven difficult to market in a global healthcare system that is more familiar with buying drugs off the shelf like consumer goods....
...J&J is following a trend in the pharmaceutical sector, as companies dispose of slower growing consumer healthcare divisions to concentrate on drug discovery....
...Science round up GlaxoSmithKline’s ViiV Healthcare is “actively negotiating” a voluntary licence on the patents for its injectable HIV prevention drug to make it more widely available in poorer nations,...
...After three failed attempts to buy UK drugmaker GlaxoSmithKline’s consumer healthcare business, Unilever refuses to back down....
...The FT editorial board said the British government needed to recognise the continuing cost burden of coronavirus on healthcare, business and schools....
...“New GSK” will not be the radical change that GlaxoSmithKline critics called for. It will retain up to 20 per cent of the consumer healthcare business post spin-off....
...The company also said it had conducted an “extensive search” to appoint a chief executive-designate for the consumer healthcare division....
...Former Tesco boss Sir Dave Lewis is set to become chair of GlaxoSmithKline’s new consumer health division, which is about to be spun off from its parent company. More here from Lex....
...Job moves GlaxoSmithKline has appointed Brian McNamara to lead its consumer health division after next year’s spin-off....
...Its attempted shake-up at Brentford-based healthcare group GlaxoSmithKline was blocked by the company’s board, which rejected Elliott’s demands to appoint new directors and re-evaluate whether chief executive...
...Dan Mahony, who co-leads the healthcare business at Polar Capital, said it was “a bit weird” that it was not GSK, the UK’s largest vaccine maker, that stepped in to help with the UK’s homegrown vaccine....
...The Mead Johnson acquisition came after a failed approach by Kapoor to acquire Pfizer’s consumer health division, which is now part of a joint venture with GlaxoSmithKline....
...It also said it was on track for its planned separation into a biopharma and consumer healthcare company in 2022....
...City Insider Lenders have given a second life to Second Home, the co-working club set up by former government adviser Rohan Silva....
French company responds to surge in demand with 25% increase in workforce because of coronavirus crisis
...The consumer healthcare business, which owns brands such as Centrum vitamins and Sensodyne toothpaste, is a joint venture with Pfizer....
...Other contenders in the race to develop the first Covid-19 vaccine include GlaxoSmithKline, Sanofi, Pfizer and Boston-based biotech Moderna....
...“Why isolate healthcare data?” she asks. “Is my healthcare data actually more sensitive than my search data? . . ....
...The first step is the break-up of the company, due by 2022, into a consumer healthcare business and separate pharma and vaccines group....
...GlaxoSmithKline and Sanofi, two of the world’s biggest vaccine makers, said they were co-operating on a vaccine for Covid-19 that could be on the market in the next 12 to 18 months....
International Edition